BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
June 11, 2007
View Archived Issues
Regeneron Completes Rolling BLA For IL-1 Trap In CAPS
Hoping to introduce the first marketed product for a group of rare chronic inflammatory conditions, Regeneron Pharmaceuticals Inc. completed a rolling biologics license application for its interleukin-1 (IL-1) Trap. (BioWorld Today)
Read More
Auxilium Stock Sale: $49.9M To Boost Enzyme Products
Read More
Biotech vs. Big Accounting: New SOX rules may help
Read More
Acorda Raises $67 Million For Second Fampridine-SR Phase III
Read More
NewCo News: Viamet Gets $4 Million Series A For Targeting Metalloenzymes
Read More
Other News To Note
Read More
Clinic Roundup
Read More
Appointments And Advancements
Read More
Financings Roundup
Read More